Herantis Pharma Oyj Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	50	49	31	32	28	27
Market Cap Growth	46.15%	60.93%	-3.81%	13.79%	4.72%	-34.19%
Enterprise Value	47	45	27	31	25	26
Last Close Price	1.88	2.04	1.51	1.57	1.65	2.28
PE Ratio	-	-	-	113.47	-	-
PB Ratio	-29.53	-29.13	-125.74	6.72	-462.92	-23.37
P/TBV Ratio	-	-	-	6.72	-	-
EV/EBITDA Ratio	-	-	-	99.84	-	-
EV/EBIT Ratio	-	-	-	203.31	-	-
Debt / Equity Ratio	-0.04	-0.04	-0.12	0.01	-75.33	-6.43
Debt / EBITDA Ratio	-	-	-	0.11	-	-
Net Debt / Equity Ratio	1.50	1.50	8.66	-1.36	24.05	0.08
Net Debt / EBITDA Ratio	-	-	-	-20.53	0.19	0.01
Net Debt / FCF Ratio	0.42	0.42	0.32	1.39	0.16	0.01
Quick Ratio	2.89	2.89	4.01	3.38	3.26	2.89
Current Ratio	2.92	2.92	4.06	3.39	3.28	2.91
Return on Equity (ROE)	-	-	-220.33%	12.00%	-	-396.06%
Return on Assets (ROA)	-152.57%	-152.57%	-67.44%	1.49%	-71.39%	-64.41%
Return on Capital Employed (ROCE)	-364.30%	-364.30%	-259.40%	3.20%	-184.60%	-242.00%
Earnings Yield	-13.29%	-13.47%	-16.17%	0.88%	-33.41%	-47.91%
FCF Yield	-	-12.40%	-21.43%	-14.60%	-32.05%	-37.28%
Buyback Yield / Dilution	-17.23%	-17.23%	-17.25%	-17.34%	-43.59%	-38.03%